Cargando…

Management of infected acute necrotizing pancreatitis

Necrotizing or severe pancreatitis represents approximately 10%-20% of acute pancreatitis. 30%-40% of patients with acute necrotizing pancreatitis (ANP) will develop debris infection through translocation of intestinal microbial flora. Infected ANP constitutes a serious clinical condition and is com...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavlidis, Efstathios T, Pavlidis, Theodoros E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850978/
https://www.ncbi.nlm.nih.gov/pubmed/36686342
http://dx.doi.org/10.12998/wjcc.v11.i2.482
_version_ 1784872306193989632
author Pavlidis, Efstathios T
Pavlidis, Theodoros E
author_facet Pavlidis, Efstathios T
Pavlidis, Theodoros E
author_sort Pavlidis, Efstathios T
collection PubMed
description Necrotizing or severe pancreatitis represents approximately 10%-20% of acute pancreatitis. 30%-40% of patients with acute necrotizing pancreatitis (ANP) will develop debris infection through translocation of intestinal microbial flora. Infected ANP constitutes a serious clinical condition and is complicated by severe sepsis with high mortality rates of up to 40% despite progress in current intensive care. The timely detection of sepsis is crucial. The Quick Sequential Organ Failure Assessment score, procalcitonin levels > 1.8 ng/mL and increased lactates > 2 mmol/L (> 18 mg/dL), indicate the need for urgent management. The escalated step-by-step management protocol starts with broad-spectrum antibiotics, percutaneous drainage or endoscopic management, and ends with surgical management if needed. The latter includes necrosectomy (either laparoscopic or traditional open surgery), peritoneal lavage and extensive drainage. This management protocol increases the chance of survival to approximately 60% in patients with otherwise fatal cases. Any treatment choice must be individualized, and the timing is critical.
format Online
Article
Text
id pubmed-9850978
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-98509782023-01-20 Management of infected acute necrotizing pancreatitis Pavlidis, Efstathios T Pavlidis, Theodoros E World J Clin Cases Letter to the Editor Necrotizing or severe pancreatitis represents approximately 10%-20% of acute pancreatitis. 30%-40% of patients with acute necrotizing pancreatitis (ANP) will develop debris infection through translocation of intestinal microbial flora. Infected ANP constitutes a serious clinical condition and is complicated by severe sepsis with high mortality rates of up to 40% despite progress in current intensive care. The timely detection of sepsis is crucial. The Quick Sequential Organ Failure Assessment score, procalcitonin levels > 1.8 ng/mL and increased lactates > 2 mmol/L (> 18 mg/dL), indicate the need for urgent management. The escalated step-by-step management protocol starts with broad-spectrum antibiotics, percutaneous drainage or endoscopic management, and ends with surgical management if needed. The latter includes necrosectomy (either laparoscopic or traditional open surgery), peritoneal lavage and extensive drainage. This management protocol increases the chance of survival to approximately 60% in patients with otherwise fatal cases. Any treatment choice must be individualized, and the timing is critical. Baishideng Publishing Group Inc 2023-01-16 2023-01-16 /pmc/articles/PMC9850978/ /pubmed/36686342 http://dx.doi.org/10.12998/wjcc.v11.i2.482 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Letter to the Editor
Pavlidis, Efstathios T
Pavlidis, Theodoros E
Management of infected acute necrotizing pancreatitis
title Management of infected acute necrotizing pancreatitis
title_full Management of infected acute necrotizing pancreatitis
title_fullStr Management of infected acute necrotizing pancreatitis
title_full_unstemmed Management of infected acute necrotizing pancreatitis
title_short Management of infected acute necrotizing pancreatitis
title_sort management of infected acute necrotizing pancreatitis
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850978/
https://www.ncbi.nlm.nih.gov/pubmed/36686342
http://dx.doi.org/10.12998/wjcc.v11.i2.482
work_keys_str_mv AT pavlidisefstathiost managementofinfectedacutenecrotizingpancreatitis
AT pavlidistheodorose managementofinfectedacutenecrotizingpancreatitis